The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions
Open accessAbstract
Endometrial cancer is the most common gynecological cancer in the developed world, and it is one of the few cancer types that is becoming more prevalent and leading to more deaths in the USA each year. The majority of endometrial tumors are considered to be hormonally driven, where estrogen signaling through estrogen receptor α (ER) acts as an oncogenic signal. The major risk factors and some treatment options for endometrial cancer patients emphasize a key role for estrogen signaling in the disease. Despite the strong connections between estrogen signaling and endometrial cancer, important molecular aspects of ER function remain poorly understood; however, progress is being made in our understanding of estrogen signaling in endometrial cancer. Here, we discuss the evidence for the importance of estrogen signaling in endometrial cancer, details of the endometrial cancer-specific actions of ER, and open questions surrounding estrogen signaling in endometrial cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Cloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,788
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,729
Hoadley, K. A., Yau, C., Hinoue, T., Wolf, D. M., Lazar, A. J., Drill, E., Shen, R., Taylor, A. M., Cherniack, A. D., Thorsson, V., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.022 · Cited by 2,546 · cited 1×
“8% of tumors harboring an ER mutation [132], representing approximately 3500 new ER mutant endometrial cancer diagnoses in the USA each year.”
BackgroundTwo pathogenetic types of endometrial carcinoma
Bokhman, J. V. (1983) · Gynecologic Oncology · doi:10.1016/0090-8258(83)90111-7 · Cited by 2,494
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,387
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Ross-Innes, C. S., Stark, R., Teschendorff, A. E., Holmes, K. A., Ali, H. R., Dunning, M. J., Brown, G. D., Gojis, O., Ellis, I. O., Green, A. R., et al. (2012) · Nature · doi:10.1038/nature10730 · Cited by 2,173
Hörlein, A. J., Näär, A. M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Söderström, M., Glass, C. K., et al. (1995) · Nature · doi:10.1038/377397a0 · Cited by 2,034
A transcriptional co-repressor that interacts with nuclear hormone receptors
Chen, J. D., & Evans, R. M. (1995) · Nature · doi:10.1038/377454a0 · Cited by 1,763
An oestrogen-receptor-α-bound human chromatin interactome
Fullwood, M. J., Liu, M. H., Pan, Y. F., Liu, J., Xu, H., Mohamed, Y. B., Orlov, Y. L., Velkov, S., Ho, A., Mei, P. H., et al. (2009) · Nature · doi:10.1038/nature08497 · Cited by 1,721
Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription
Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., & Brown, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00188-4 · Cited by 1,657
Chen, H., Lin, R. J., Schiltz, R. L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M. L., Nakatani, Y., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80516-4 · Cited by 1,465
Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
Thomas, P., Pang, Y., Filardo, E. J., & Dong, J. (2005) · Endocrinology · doi:10.1210/en.2004-1064 · Cited by 1,407
Differential Oestrogen Receptor Binding is Associated with Clinical Outcome in Breast Cancer
Stark, R. (2012) · Lecture Notes in Computer Science · doi:10.1007/978-3-642-29627-7_30 · Cited by 1,403
Genome-wide analysis of estrogen receptor binding sites
Carroll, J. S., Meyer, C. A., Song, J., Li, W., Geistlinger, T. R., Eeckhoute, J., Brodsky, A. S., Keeton, E. K., Fertuck, K. C., Hall, G. F., et al. (2006) · Nature Genetics · doi:10.1038/ng1901 · Cited by 1,377
Fisher, B., Costantino, J. P., Redmond, C. K., Fisher, E. R., Wickerham, D. L., Cronin, W. M., & Contributors, O. N. (1994) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/86.7.527 · Cited by 1,268
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Toy, W., Shen, Y., Won, H., Green, B., Sakr, R. A., Will, M., Li, Z., Gala, K., Fanning, S., King, T. A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2822 · Cited by 1,248
The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer
Kumar, V., & Chambon, P. (1988) · Cell · doi:10.1016/0092-8674(88)90017-7 · Cited by 1,220
Molecular Determinants for the Tissue Specificity of SERMs
Shang, Y., & Brown, M. (2002) · Science · doi:10.1126/science.1068537 · Cited by 1,146
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Robinson, D. R., Wu, Y.-M., Vats, P., Su, F., Lonigro, R. J., Cao, X., Kalyana-Sundaram, S., Wang, R., Ning, Y., Hodges, L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2823 · Cited by 1,145
Nongenomic actions of steroid hormones
Lösel, R., & Wehling, M. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1009 · Cited by 980
FOXA1 is a key determinant of estrogen receptor function and endocrine response
Hurtado, A., Holmes, K. A., Ross-Innes, C. S., Schmidt, D., & Carroll, J. S. (2011) · Nature Genetics · doi:10.1038/ng.730 · Cited by 844
Type I and II Endometrial Cancers: Have They Different Risk Factors?
Setiawan, V. W., Yang, H. P., Pike, M. C., McCann, S. E., Yu, H., Xiang, Y.-B., Wolk, A., Wentzensen, N., Weiss, N. S., Webb, P. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.2596 · Cited by 827
Danielian, P. S., White, R., Lees, J. A., & Parker, M. G. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05141.x · Cited by 803
International patterns and trends in endometrial cancer incidence, 1978-2013.
Lortet-Tieulent, J., Ferlay, J., Bray, F., & Jemal, A. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx214 · Cited by 760
Schwabe, J. W. R., Chapman, L., Finch, J. T., & Rhodes, D. (1993) · Cell · doi:10.1016/0092-8674(93)90390-c · Cited by 750
Crystallographic comparison of the estrogen and progesterone receptor’s ligand binding domains
Tanenbaum, D. M., Wang, Y., Williams, S. P., & Sigler, P. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5998 · Cited by 738
Cloning of the human estrogen receptor cDNA.
Walter, P., Green, S., Greene, G., Krust, A., Bornert, J. M., Jeltsch, J. M., Staub, A., Jensen, E., Scrace, G., & Waterfield, M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.7889 · Cited by 730
Klein-Hitpaß, L., Schorpp, M., Wagner, U., & Ryffel, G. U. (1986) · Cell · doi:10.1016/0092-8674(86)90705-1 · Cited by 720
Hong, H., Kohli, K., Trivedi, A., Johnson, D. L., & Stallcup, M. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4948 · Cited by 697
Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells
PIETRAS, R. J., & SZEGO, C. M. (1977) · Nature · doi:10.1038/265069a0 · Cited by 691
Jeselsohn, R., Yelensky, R., Buchwalter, G., Frampton, G., Meric-Bernstam, F., Gonzalez-Angulo, A. M., Ferrer-Lozano, J., Perez-Fidalgo, J. A., Cristofanilli, M., Gómez, H., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2332 · Cited by 674
Obesity as disruptor of the female fertility
Silvestris, E., de Pergola, G., Rosania, R., & Loverro, G. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0336-z · Cited by 664
Progesterone receptor modulates ERα action in breast cancer
Mohammed, H., Russell, I. A., Stark, R., Rueda, O. M., Hickey, T. E., Tarulli, G. A., Serandour, A. A., Birrell, S. N., Bruna, A., Saadi, A., et al. (2015) · Nature · doi:10.1038/nature14583 · Cited by 659
Risk factors for endometrial cancer: An umbrella review of the literature
Raglan, O., Kalliala, I., Markozannes, G., Cividini, S., Gunter, M. J., Nautiyal, J., Gabra, H., Paraskevaidis, E., Martin‐Hirsch, P., Tsilidis, K. K., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.31961 · Cited by 648
Li, S., Shen, D., Shao, J., Crowder, R., Liu, W., Prat, A., He, X., Liu, S., Hoog, J., Lu, C., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.022 · Cited by 626
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
Berger, A. C., Korkut, A., Kanchi, R. S., Hegde, A. M., Lenoir, W., Liu, W., Liu, Y., Fan, H., Shen, H., Ravikumar, V., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.014 · Cited by 620
Carmeci, C., Thompson, D. A., Ring, H. Z., Francke, U., & Weigel, R. J. (1997) · Genomics · doi:10.1006/geno.1997.4972 · Cited by 591
BioID: A Screen for Protein‐Protein Interactions
Roux, K. J., Kim, D. I., & Burke, B. (2013) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps1923s74 · Cited by 498
Thigpen, J. T., Brady, M. F., Alvarez, R. D., Adelson, M. D., Homesley, H. D., Manetta, A., Soper, J. T., & Given, F. T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1736 · Cited by 484
Enhancer transcripts mark active estrogen receptor binding sites
Hah, N., Murakami, S., Nagari, A., Danko, C. G., & Kraus, W. L. (2013) · Genome Research · doi:10.1101/gr.152306.112 · Cited by 476
Estrogen Receptor α Rapidly Activates the IGF-1 Receptor Pathway
Kahlert, S., Nuedling, S., van Eickels, M., Vetter, H., Meyer, R., & Grohé, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910345199 · Cited by 474
Whole-Genome Cartography of Estrogen Receptor α Binding Sites
Lin, C.-Y., Vega, V. B., Thomsen, J. S., Zhang, T., Kong, S. L., Xie, M., Chiu, K. P., Lipovich, L., Barnett, D. H., Stossi, F., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030087 · Cited by 459
HEMSELL, D. L., GRODIN, J. M., BRENNER, P. F., SIITERI, P. K., & MACDONALD, P. C. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-3-476 · Cited by 444
History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target
Santen, R. J., Brodie, H., Simpson, E. R., Siiteri, P. K., & Brodie, A. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0016 · Cited by 442
Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Gottardis, M. M., Robinson, S. P., SATYASWAROOP, P. G., & Jordan, V. C. (1988) · PubMed · Cited by 422
An Approach to Spatiotemporally Resolve Protein Interaction Networks in Living Cells
Lobingier, B. T., Hüttenhain, R., Eichel, K., Miller, K. B., Ting, A. Y., von Zastrow, M., & Krogan, N. J. (2017) · Cell · doi:10.1016/j.cell.2017.03.022 · Cited by 412
Physical Activity, Body Mass Index, and Ovulatory Disorder Infertility
Rich-Edwards, J. W., Spiegelman, D., Garland, M., Hertzmark, E., Hunter, D. J., Colditz, G. A., Willett, W. C., Wand, H., & Manson, J. E. (2002) · Epidemiology · doi:10.1097/00001648-200203000-00013 · Cited by 411
Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory Factor
Mohammed, H., D’Santos, C., Serandour, A. A., Ali, H. R., Brown, G. D., Atkins, A., Rueda, O. M., Holmes, K. A., Theodorou, V., Robinson, J. L. L., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.010 · Cited by 400
ChIP‐Seq of ERα and RNA polymerase II defines genes differentially responding to ligands
Welboren, W., van Driel, M. A., Janssen‐Megens, E. M., van Heeringen, S. J., Sweep, F. C., Span, P. N., & Stunnenberg, H. G. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.88 · Cited by 395
Merenbakh-Lamin, K., Ben-Baruch, N., Yeheskel, A., Dvir, A., Soussan-Gutman, L., Jeselsohn, R., Yelensky, R., Brown, M., Miller, V. A., Sarid, D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1197 · Cited by 393
Endometrial Cancer and Estrogen Use: Report of a Large Case-Control Study
Antunes, C. M. F., Stolley, P. D., Rosenshein, N. B., Davies, J. L., Tonascia, J. A., Brown, C., Burnett, L., Rutledge, A., Pokempner, M., & Garcia, R. (1979) · New England Journal of Medicine · doi:10.1056/nejm197901043000103 · Cited by 388
Gallos, I. D., Yap, J., Rajkhowa, M., Luesley, D. M., Coomarasamy, A., & Gupta, J. K. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.08.011 · Cited by 382
Distinct Properties of Cell-Type-Specific and Shared Transcription Factor Binding Sites
Gertz, J., Savic, D., Varley, K. E., Partridge, E. C., Safi, A., Jain, P., Cooper, G. M., Reddy, T. E., Crawford, G. E., & Myers, R. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.037 · Cited by 376
Self-citationSafe, S., & Kim, K. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0103 · Cited by 368
Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists
Toy, W., Weir, H., Razavi, P., Lawson, M., Goeppert, A. U., Mazzola, A. M., Smith, A., Wilson, J., Morrow, C., Wong, W. L., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1523 · Cited by 368
GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility
Theodorou, V., Stark, R., Menon, S., & Carroll, J. S. (2013) · Genome Research · doi:10.1101/gr.139469.112 · Cited by 367
Newbold, R. R., Bullock, B. C., & McLachlan, J. A. (1990) · PubMed · Cited by 314
Fanning, S. W., Mayne, C. G., Dharmarajan, V., Carlson, K. E., Martin, T. A., Novick, S. J., Toy, W., Green, B., Panchamukhi, S., Katzenellenbogen, B. S., et al. (2016) · eLife · doi:10.7554/elife.12792 · Cited by 314
Pan, D., Kocherginsky, M., & Conzen, S. D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0362 · Cited by 296
Zhang, Q., Borg, Å., Wolf, D. M., Oesterreich, S., & Fuqua, S. A. W. (1997) · PubMed · Cited by 291
Endometrial Cancer and Lynch Syndrome: Clinical and Pathologic Considerations
Meyer, L. A., Broaddus, R. R., & Lu, K. H. (2009) · Cancer Control · doi:10.1177/107327480901600103 · Cited by 281
Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations
Jeselsohn, R., Bergholz, J. S., Pun, M., Cornwell, M., Liu, W., Nardone, A., Xiao, T., Li, W., Qiu, X., Buchwalter, G., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.004 · Cited by 276
Fiorica, J. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.11.008 · Cited by 249
Walker, P., Germond, J.-E., Brown-Luedi, M., Givel, F., & Wahli, W. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.22.8611 · Cited by 247
Krishnan, V., Wang, X., & Safe, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40767-8 · Cited by 243
The Normal Menstrual Cycle and the Control of Ovulation
Reed, B. G., & Carr, B. R. (2015) · Europe PMC (PubMed Central) · Cited by 236
Weis, K. E. (1996) · Molecular Endocrinology · doi:10.1210/me.10.11.1388 · Cited by 236
Dobbins, M., Decorby, K., & Choi, B. C. K. (2013) · ISRN Preventive Medicine · doi:10.5402/2013/680536 · Cited by 227
Owman, C., Blay, P., Nilsson, C., & Lolait, S. J. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1654 · Cited by 224
Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance
Katzenellenbogen, J. A., Mayne, C. G., Katzenellenbogen, B. S., Greene, G. L., & Chandarlapaty, S. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0001-z · Cited by 216
Kurita, T., Young, P., Brody, J. R., Lydon, J. P., O’Malley, B. W., & Cunha, G. R. (1998) · Endocrinology · doi:10.1210/endo.139.11.6317 · Cited by 205
Estrogen and the endometrium: lessons learned from gene expression profiling in rodents and human
Groothuis, P. G., Dassen, H. H. N. M., Romano, A., & Punyadeera, C. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm009 · Cited by 202
Rose, P. G., Brunetto, V. L., VanLe, L., Bell, J., Walker, J. L., & Lee, R. B. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5865 · Cited by 199
Whitney, C. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.09.018 · Cited by 193
Thigpen, T., Brady, M. F., Homesley, H. D., Soper, J. T., & Bell, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.364 · Cited by 191
Métivier, R., Penot, G., Flouriot, G., & Pakdel, F. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.11.0727 · Cited by 189
Lentz, S. S., Brady, M. F., Major, F. J., Reid, G. C., & Soper, J. T. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.357 · Cited by 187
Structure of a Biologically Active Estrogen Receptor-Coactivator Complex on DNA
Yi, P., Wang, Z., Feng, Q., Pintilie, G. D., Foulds, C. E., Lanz, R. B., Ludtke, S. J., Schmid, M. F., Chiu, W., & O’Malley, B. W. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.025 · Cited by 184
Integrative model of genomic factors for determining binding site selection by estrogen receptor‐α
Joseph, R., Orlov, Y. L., Huss, M., Sun, W., Kong, S. L., Ukil, L., Pan, Y. F., Li, G., Lim, M., Thomsen, J. S., et al. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.109 · Cited by 180
Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics
He, H. H., Meyer, C. A., Chen, M. W., Jordan, V. C., Brown, M., & Liu, X. S. (2012) · Genome Research · doi:10.1101/gr.133280.111 · Cited by 177
Progesterone and the Luteal Phase
Mesen, T. B., & Young, S. L. (2015) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2014.10.003 · Cited by 167
Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer
Jordan, V. C. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-14-0092 · Cited by 165
Lupien, M., Meyer, C. A., Bailey, S. T., Eeckhoute, J., Cook, J., Westerling, T., Zhang, X., Carroll, J. S., Rhodes, D. R., Liu, X. S., et al. (2010) · Genes & Development · doi:10.1101/gad.1944810 · Cited by 165
Gertz, J., Reddy, T. E., Varley, K. E., Garabedian, M. J., & Myers, R. (2012) · Genome Research · doi:10.1101/gr.135681.111 · Cited by 164
Self-citationJongen, V., Briët, J., de Jong, R., ten Hoor, K., Boezen, M., van der Zee, A., Nijman, H., & Hollema, H. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.10.032 · Cited by 162
Bahreini, A., Li, Z., Wang, P., Levine, K. M., Tasdemir, N., Cao, L., Weir, H. M., Puhalla, S. L., Davidson, N. E., Stern, A. M., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0851-4 · Cited by 160
Estrogen Receptors: Structure, Mechanisms and Function
Hewitt, S. C., & Korach, K. S. (2002) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1020068224909 · Cited by 158
Singhal, H., Greene, M. E., Tarulli, G. A., Zarnke, A. L., Bourgo, R. J., Lainé, M., Chang, Y.-F., Ma, S., Dembo, A. G., Raj, G. V., et al. (2016) · Science Advances · doi:10.1126/sciadv.1501924 · Cited by 156
Baker, J., Obermair, A., Gebski, V., & Janda, M. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.11.043 · Cited by 155
Deciphering the divergent roles of progestogens in breast cancer
Carroll, J. S., Hickey, T. E., Tarulli, G. A., Williams, M. R., & Tilley, W. D. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.116 · Cited by 148
Franco, H. L., Nagari, A., & Kraus, W. L. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.001 · Cited by 146
Estrogen receptor β: the guardian of the endometrium
Hapangama, D. K., Kamal, A. M., & Bulmer, J. N. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu053 · Cited by 145
Long term health consequences of polycystic ovarian syndrome: a review analysis.
Daniilidis, A., & Dinas, K. D. (2009) · Europe PMC (PubMed Central) · Cited by 140
Miranda, T. B., Voss, T. C., Sung, M.-H., Baek, S., John, S., Hawkins, M., Grøntved, L., Schiltz, R. L., & Hager, G. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0742 · Cited by 130
The genomics and genetics of endometrial cancer
Bell, D. W., & Ohara (2012) · Advances in Genomics and Genetics · doi:10.2147/agg.s28953 · Cited by 129
Carleton, J. B., Berrett, K. C., & Gertz, J. (2017) · Cell Systems · doi:10.1016/j.cels.2017.08.011 · Cited by 125
Self-citationZwart, W. T., de Leeuw, R., Rondaij, M. G., Neefjes, J., Mancini, M. A., & Michalides, R. J. A. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.061135 · Cited by 108
Past, present, and future of hormonal therapy in recurrent endometrial cancer
Leslie, K. K., Thiel, K. W., & Carlson, M. J. (2014) · International Journal of Women s Health · doi:10.2147/ijwh.s40942 · Cited by 99
Vollmer, G. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100023 · Cited by 89
Endocrine Therapy for Early Breast Cancer: Updated Review.
Tremont, A., Lu, J., & COLE, J. T. (2017) · PubMed Central · Cited by 88
Aromatase activity of membrane fractions of human adipose tissue stromal cells and adipocytes
CLELAND, W. H., MENDELSON, C. R., & SIMPSON, E. R. (1983) · Endocrinology · doi:10.1210/endo-113-6-2155 · Cited by 86
Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight
Fuqua, S. A. W., Gu, G., & Rechoum, Y. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2847-4 · Cited by 85
McMeekin, D. S., Gordon, A. N., Fowler, J. M., Melemed, A. S., Buller, R. E., Burke, T. J., Bloss, J., & Sabbatini, P. J. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00203-8 · Cited by 82
Vahrenkamp, J. M., Yang, C.-H., Rodriguez, A. C., Almomen, A. A., Berrett, K. C., Trujillo, A., Guillen, K. P., Welm, B. E., Jarboe, E. A., Janat-Amsbury, M. M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.076 · Cited by 81
Self-citationObesity and anovulatory infertility: A review
Giviziez, C. R., Sanchez, E. G. M., Approbato, M. S., Maia, M. C. S., Fleury, E. A. D. B., & Sasaki, R. S. A. (2016) · JBRA · doi:10.5935/1518-0557.20160046 · Cited by 78
Pakdel, F., Reese, J. C., & Katzenellenbogen, B. S. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.11.8114756 · Cited by 77
Genetic basis of Cowden syndrome and its implications for clinical practice and risk management
Gammon, A., Jasperson, K. W., & Champine, M. (2016) · The Application of Clinical Genetics · doi:10.2147/tacg.s41947 · Cited by 77
Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome
Deng, Y., Zhang, Y., Li, S., Zhou, W., Ye, L., Wang, L., Tao, T., Gu, J., Yang, Z., Zhao, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14534-2 · Cited by 68
Heldring, N., Isaacs, G. D., Diehl, A. G., Sun, M., Cheung, E. C. W., Ranish, J. A., & Kraus, W. L. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0425 · Cited by 66
Velardo, J. T., Hisaw, F., & Bever, A. T. (1956) · Endocrinology · doi:10.1210/endo-59-2-165 · Cited by 65
Zhao, Y., Laws, M. J., Guillen, V. S., Ziegler, Y., Min, J., Sharma, A., Kim, S. H., Chu, D. T. W., Park, B. H., Oesterreich, S., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1265 · Cited by 63
Contemporary Clinical Management of Endometrial Cancer
Dinkelspiel, H. E., Wright, J. D., Lewin, S. N., & Herzog, T. J. (2013) · Obstetrics and Gynecology International · doi:10.1155/2013/583891 · Cited by 62
Estrogen-independent molecular actions of mutant estrogen receptor 1 in endometrial cancerPreprint
Blanchard, Z., Vahrenkamp, J. M., Berrett, K. C., Arnesen, S., & Gertz, J. (2019) · Genome Research · doi:10.1101/gr.244780.118 · Cited by 62
Self-citationYang, C., Almomen, A. A., Wee, Y. S., Jarboe, E. A., Peterson, C. M., & Janat-Amsbury, M. M. (2015) · Cancer Medicine · doi:10.1002/cam4.445 · Cited by 54
Effects of metformin on mammalian target of rapamycin in a mouse model of endometrial hyperplasia
Erdemoğlu, E., Güney, M., Giray, S. G., Take, G., & Mungan, T. (2009) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2009.04.034 · Cited by 54
Bartosch, C., Monteiro‐Reis, S., Vieira, R., Pereira, A., Rodrigues, M., Jerónimo, C., & Lopes, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134969 · Cited by 42
Skrzypczak, M., Schüler, S., Lattrich, C., Ignatov, A., Ortmann, O., & Treeck, O. (2013) · Steroids · doi:10.1016/j.steroids.2013.07.007 · Cited by 37
Steroid receptor coactivators as therapeutic targets in the female reproductive system
Szwarc, M. M., Lydon, J. P., & O’Malley, B. W. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.06.010 · Cited by 33
Differential Inhibition by Cortisol of Estrogen-Stimulated Uterine Responses
BITMAN, J., & CECIL, H. C. (1967) · Endocrinology · doi:10.1210/endo-80-3-423 · Cited by 32
Historical Perspectives: An abridged history of sex steroid hormone receptor action
Fannon, S. A., Vidaver, R. M., & Marts, S. A. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.4.1854 · Cited by 26
Sikora, M. J. (2016) · Endocrinology · doi:10.1210/en.2016-1778 · Cited by 26
Droog, M., Nevedomskaya, E., Dackus, G. M. H. E., Fles, R., Kim, Y., Hollema, H., Mourits, M. J. E., Nederlof, P. M., van Boven, H. H., Linn, S. C., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615233114 · Cited by 25
Coons, L. A., Hewitt, S. C., Burkholder, A., McDonnell, D. P., & Korach, K. S. (2017) · Endocrinology · doi:10.1210/en.2017-00468 · Cited by 22
Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines
Carleton, J. B., Berrett, K. C., & Gertz, J. (2018) · Journal of Visualized Experiments · doi:10.3791/57883 · Cited by 10
Self-citationFulvestrant for the treatment of endometrial cancer
Battista, M. J., & Schmidt, M. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1154532 · Cited by 8
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancerPreprint
Blanchard, Z., Vahrenkamp, J. M., Berrett, K. C., Arnesen, S., & Gertz, J. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/369165 · Cited by 3
Self-citation
Metadata
- Authors
- Rodriguez, A. C., Blanchard, Z., Maurer, K. A., & Gertz, J.
- Venue
- Hormones and Cancer
- Published
- 2019-02-02
- Volume
- 10
- Issue
- 2-3
- Pages
- 51-63
- ISSN
- 1868-8497 (ISSN-L)
- 1868-8500
- OpenAlex
- W2913100284
- Cited by
- 291
- References
- 129
- FWCI
- 16.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.